newsfilter
← Latest News
Business Wire·

Intersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan

Intersect ENT, Inc. (NASDAQ:XENT), a global ear, nose and throat ("ENT") medical technology leader dedicated to transforming patient care, today announced preliminary second quarter 2021 revenue and provided a business update. Second Quarter 2021 Ove